Your browser doesn't support javascript.
loading
Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of N-methyl-D-aspartate (NMDA).
Shiozawa, Asaka Lee; Igarashi, Tsutomu; Kobayashi, Maika; Nakamoto, Kenji; Kameya, Shuhei; Fujishita, Shigeto; Takahashi, Hiroshi; Okada, Takashi.
Affiliation
  • Shiozawa AL; Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
  • Igarashi T; Department of Drug Discovery Research, Teika Pharmaceutical Co., Ltd., Toyama, Japan.
  • Kobayashi M; Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
  • Nakamoto K; Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
  • Kameya S; Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan.
  • Fujishita S; Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
  • Takahashi H; Department of Ophthalmology, Nippon Medical School, Tokyo, Japan.
  • Okada T; Department of Ophthalmology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
Mol Vis ; 26: 409-422, 2020.
Article in En | MEDLINE | ID: mdl-32565669
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Retinal Diseases / Genetic Therapy / N-Methylaspartate / Brain-Derived Neurotrophic Factor Type of study: Prognostic_studies Language: En Journal: Mol Vis Year: 2020 Type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Retinal Diseases / Genetic Therapy / N-Methylaspartate / Brain-Derived Neurotrophic Factor Type of study: Prognostic_studies Language: En Journal: Mol Vis Year: 2020 Type: Article Affiliation country: Japan